Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it is better equipped in some material and technical areas than before COVID-19. Preparedness has improved in stockpiles, certain surveillance systems, and rapid-response platforms due to post-2020 investments, but persistent systemic gaps in leadership/coordination, sustained funding, workforce, R&D priorities, public trust, and implementation of lessons learned leave significant vulnerabilities. Recent policy shifts (2025–2026) have further eroded capacity in key areas, according to experts, GAO reports, bipartisan commissions, and assessments like Trust for America’s Health (TFAH).[1][2][3]
Preparedness is not binary—it involves prevention, detection, response, medical countermeasures (MCMs like vaccines/therapeutics), supply chains, healthcare surge capacity, communication, equity, and global cooperation. The US has made progress but faces a familiar “panic-neglect” cycle, and current trajectories raise concerns.
Improvements Since COVID-19
These built on pre-existing frameworks like the Pandemic and All-Hazards Preparedness Act (PAHPA) and Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).
Persistent and Emerging Gaps
TFAH’s 2026 report highlights compounding 2025 emergencies (severe flu, measles, H5N1, weather events) amid federal strain, with uneven state readiness and calls to restore workforce, reauthorize PAHPA, stabilize funding, and bolster immunization/surveillance. Experts (e.g., former officials, virologists) describe recent changes as damaging preparedness and leaving the US “not ready.”[3][14]
Broader Context and Outlook
Biological threats (natural, accidental, or deliberate) are growing due to climate, travel, urbanization, dual-use research, and adversarial programs. Models suggest a substantial chance of another major pandemic in coming decades. The US has tools and knowledge from COVID (e.g., faster vaccine platforms when prioritized, better data systems), and private sector/state capacity can fill some gaps. However, without sustained bipartisan investment, clear leadership, evidence-based priorities, workforce rebuilding, and restored trust/cooperation, response to a severe novel pathogen would likely face delays in detection, MCMs, distribution, hospital overload, economic disruption, and uneven impacts—similar to or worse than early COVID in some respects.
Progress is possible and has occurred before (e.g., post-anthrax, post-H1N1 investments). Recommendations from GAO, the Biodefense Commission, TFAH, ACP, and others emphasize White House coordination, multi-year MCM funding, modernized detection/surveillance, indoor protections, supply chain resilience, equity-focused planning, and reauthorizing/strengthening laws like PAHPA. States and non-federal actors are stepping up in places, but federal systems remain central.[12][10]
In summary, material improvements exist, but incomplete lesson implementation, funding instability, workforce losses, R&D deprioritization, and eroded coordination/trust mean the US is not adequately prepared overall for another major crisis. Ongoing threats like H5N1 and measles serve as real-time tests of these systems.
Citations (18)
- https://www.gao.gov/products/gao-24-107175
Backs: “Recent policy shifts (2025–2026) have further eroded capacity in key areas, according to experts, GAO reports, bipartisan commissions, and assessments like Trust for America’s Health (TFAH).”
evidence, official document, points to no. Claim: GAO flags HHS leadership and coordination of public health emergencies as a high-risk gap, with many COVID recommendations still open.
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Recent policy shifts (2025–2026) have further eroded capacity in key areas, according to experts, GAO reports, bipartisan commissions, and assessments like Trust for America’s Health (TFAH).”
attribution, article, points to no. Claim: Experts and assessments find persistent preparedness gaps and vulnerabilities.
- https://www.theguardian.com/us-news/2026/may/17/pandemic-preparedness-after-covid
Backs: “Recent policy shifts (2025–2026) have further eroded capacity in key areas, according to experts, GAO reports, bipartisan commissions, and assessments like Trust for America’s Health (TFAH).”
attribution, article, points to no. Claim: Experts say recent policy changes damaged preparedness and left the US not ready; global engagement decreased.
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Jurisdictional (state/local) stockpiles are also being emphasized as a layered system.”
evidence, official document, points to yes. Claim: Stockpile restocked with far more PPE; surveillance and e-case reporting expanded after COVID.
- https://www.aspr.gov/readiness-response/medical-countermeasures-biodefense/sns/stockpile-products/inventory-overview
Backs: “Jurisdictional (state/local) stockpiles are also being emphasized as a layered system.”
evidence, data page, points to yes. Claim: Strategic National Stockpile holds substantial inventory of supplies and countermeasures.
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: ““Warm base” lab contracts and quality controls for testing were established.”
statistic, official document, points to yes. Claim: Electronic case reporting grew from under 200 facilities to over 45,000 by 2024.
- https://www.drugtopics.com/view/hhs-awards-moderna-176-million-to-develop-pandemic-ready-influenza-vaccine
Backs: “Global efforts included dose donations and support for funds like the Pandemic Fund.”
evidence, article, points to yes. Claim: HHS invested in Moderna pandemic-ready influenza vaccine development.
- https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca
Backs: “Global efforts included dose donations and support for funds like the Pandemic Fund.”
evidence, article, neutral. Claim: Pandemic preparedness efforts and investments spanned the Trump and Biden administrations.
- https://www.acpjournals.org/doi/10.7326/M23-0768
Backs: “Some states strengthened lab surge plans, nurse licensure compacts (41 states by early 2026), and accreditation.”
evidence, article, points to yes. Claim: PREVENT Pandemics Act created the White House pandemic preparedness office and incorporated lessons.
- https://www.tfah.org/report-details/ready-or-not-2026/
Backs: “Some states strengthened lab surge plans, nurse licensure compacts (41 states by early 2026), and accreditation.”
evidence, official document, points to no. Claim: TFAH Ready or Not 2026 shows uneven state readiness, workforce strain, funding cuts, low vaccination, and measles resurgence.
- https://www.gao.gov/products/gao-23-106829
Backs: “The Bipartisan Commission on Biodefense’s 2024 National Blueprint stated the nation “remains dangerously vulnerable,” urging stronger White House leadership (e.g., codifying National Security Advisor roles), better intelligence/attribution, and ending fragmentation across 15+ departments/agencies.”
statistic, official document, points to no. Claim: About 220 of 428 COVID-related recommendations remained open; HHS leadership gaps.
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “The Bipartisan Commission on Biodefense’s 2024 National Blueprint stated the nation “remains dangerously vulnerable,” urging stronger White House leadership (e.g., codifying National Security Advisor roles), better intelligence/attribution, and ending fragmentation across 15+ departments/agencies.”
attribution, official document, points to no. Claim: Bipartisan Commission on Biodefense says nation remains dangerously vulnerable and fragmented.
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Some states cut public health funding amid federal instability. TFAH and others warn this compounds risks.”
evidence, article, points to no. Claim: Countermeasure enterprise faces multi-billion-dollar funding shortfalls.
- https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic
Backs: “Some states cut public health funding amid federal instability. TFAH and others warn this compounds risks.”
evidence, article, points to no. Claim: Trump administration is dismantling pandemic-fighting efforts, including cuts and mRNA project cancellations.
- https://www.biopharmadive.com/news/mrna-vaccine-cuts-kennedy-us-science-risk-leadership/757694/
Backs: “Detection systems like BioWatch have long been criticized as inadequate.”
evidence, article, points to no. Claim: mRNA vaccine funding cuts risk US scientific leadership.
- https://geneticliteracyproject.org/2026/10/26/in-trump-administration-redirect-u-s-steers-nih-sharply-away-from-biodefense-and-pandemic-preparedness/
Backs: “Detection systems like BioWatch have long been criticized as inadequate.”
evidence, article, points to no. Claim: NIH steered away from biodefense and pandemic preparedness.
- https://files.kff.org/attachment/fact-sheet-the-trump-administrations-foreign-aid-review-status-of-global-health-security-pandemic-preparedness.pdf
Backs: “Global engagement has decreased (e.g., WHO withdrawal processes, reduced GHS focus, rejection of certain UN declarations), raising importation risks since threats are transnational.”
evidence, official document, points to no. Claim: Foreign aid review reduced global health security and pandemic preparedness focus.
- https://www.gao.gov/assets/gao-21-513-highlights.pdf
Backs: “Exercises and after-action processes have not fully closed long-standing gaps.”
evidence, official document, points to no. Claim: Exercises and after-action processes have not fully closed long-standing gaps.